Identification and characterization of murine alternatively spliced tissue factor

被引:42
作者
Bogdanov, VY
Kirk, RI
Miller, C
Hathcock, JJ
Vele, S
Gazdoiu, M
Nemerson, Y
Taubman, MB
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA
[3] Univ Rochester, Sch Med & Dent, Ctr Cellular & Mol Cardiol, Rochester, NY USA
[4] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY USA
关键词
alternative splicing; development; thrombosis; tissue factor;
D O I
10.1111/j.1538-7836.2005.01680.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor (TF) is a transmembrane glycoprotein that initiates coagulation and plays a critical role in regulating hemostasis and thrombosis. We have recently reported a naturally occurring, soluble form of human tissue factor (asTF) generated by alternative splicing. This splice variant has a novel C-terminus with no homology to that of the full-length TF (flTF), lacks a transmembrane domain, and is active in the presence of phospholipids. Mouse models offer unique opportunities to examine the relative importance of flTF and asTF in mediating thrombosis, the response to arterial injury, and ischemic damage. To that end, we have identified and characterized murine asTF (masTF). Like the human splice variant, masTF lacks a transmembrane domain and has a unique C-terminus. We have generated antibodies specific to masTF and murine flTF (mflTF) to examine the expression of both forms of TF. masTF antigen is widely and abundantly expressed, with a pattern similar to that of mflTF, in adult tissues, in experimentally induced thrombi, and during development. These studies demonstrate that masTF contributes to the pool of total TF and may thus play an important role in mediating TF-dependent processes.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 38 条
[1]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[2]   Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein [J].
Bogdanov, VY ;
Balasubramanian, V ;
Hathcock, J ;
Vele, O ;
Lieb, M ;
Nemerson, Y .
NATURE MEDICINE, 2003, 9 (04) :458-462
[3]  
CARSON SD, 1994, BLOOD, V84, P526
[4]  
Chang JY, 1999, THROMB HAEMOSTASIS, V81, P45
[5]   In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant [J].
Combes, V ;
Simon, AC ;
Grau, GE ;
Arnoux, D ;
Camoin, L ;
Sabatier, F ;
Mutin, M ;
Sanmarco, M ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :93-102
[6]   Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass - Extrinsic pathway inhibition eliminates luminal narrowing [J].
Courtman, DW ;
Schwartz, SM ;
Hart, CE .
CIRCULATION RESEARCH, 1998, 82 (09) :996-1006
[7]  
EDGINGTON TS, 1991, THROMB HAEMOSTASIS, V66, P67
[8]   Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation [J].
Erlich, JH ;
Boyle, EM ;
Labriola, J ;
Kovacich, JC ;
Santucci, RA ;
Fearns, C ;
Morgan, EN ;
Yun, W ;
Luther, T ;
Kojikawa, O ;
Martin, TR ;
Pohlman, TH ;
Verrier, ED ;
Mackman, N .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (06) :1849-1862
[9]   Blood-borne tissue factor:: Another view of thrombosis [J].
Giesen, PLA ;
Rauch, U ;
Bohrmann, B ;
Kling, D ;
Roqué, M ;
Fallon, JT ;
Badimon, JJ ;
Himber, J ;
Riederer, MA ;
Nemerson, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2311-2315
[10]   Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat [J].
Han, X ;
Girard, TJ ;
Baum, P ;
Abendschein, DR ;
Broze, GJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2563-2567